Find clinical trials for Lung Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma

Cancer

Small Cell Lung Carcinoma

Carcinoma

Colorectal Cancer

Squamous Cell Carcinoma of Head and Neck

Neoplasm Metastasis

Lung Cancer trials near Berlin, BE, DEU:

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting

Non-small Cell Lung Cancer

Drug: Docetaxel

Drug: DS-1062a

Phase 3

Daiichi Sankyo

Berlin, Germany and 210 other locations

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...

Enrolling

Metastatic Non Small Cell Lung Cancer

Drug: Pembrolizumab

Drug: Carboplatin

Phase 3

Daiichi Sankyo

Berlin, Germany and 254 other locations

Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung01)

results observed in participants with Extensive-stage Small Cell Lung Cancer (ES-SCLC) who received at least 1 prior line of platin...

Active, not recruiting

Extensive-stage Small-cell Lung Cancer

Drug: Ifinatamab Deruxtecan (I-DXd)

Phase 2

Daiichi Sankyo

Berlin, Germany and 57 other locations

Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)

The aim of the DigiNet project is to improve the treatment of patients with advanced non-small cell lung cancer (NSCLC) in Germany. ...

Active, not recruiting

Non-small Cell Lung Cancer Stage IV

Other: DigiNet intervention

University of Cologne

Berlin, Germany and 40 other locations

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

overall response rate (ORR) when compared to nivolumab plus PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung...

Active, not recruiting

Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Drug: Nab-Paclitaxel

Drug: Cisplatin

Phase 2

Bristol-Myers Squibb (BMS)

Berlin, Germany and 126 other locations

Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)

disease small-cell lung cancer (SCLC)....

Active, not recruiting

Small Cell Lung Cancer Limited Stage

Drug: Durvalumab

Drug: standard of care

Phase 2

Michael Hopp

Potsdam, Brandenburg, Germany and 15 other locations

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer (IDeate-Lung02)

study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...

Enrolling

Small Cell Lung Cancer

Drug: Topotecan

Drug: Amrubicin

Phase 3

Daiichi Sankyo

Berlin, Germany and 233 other locations

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON...

Enrolling

Lung Cancer Stage IV, Advanced Solid Tumor, Cancer

Non-Small Cell Lung Cancer, NSCLC

Drug: RMC-9805

Drug: RMC-6236

Phase 1, Phase 2

Revolution Medicines

Berlin, Germany and 63 other locations

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer (Krascendo 1)

KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung...

Enrolling

KRAS G12C Lung Cancer

Non-Small Cell Lung Cancer

Drug: Sotorasib

Drug: Divarasib

Phase 3

Roche

Berlin, Germany and 253 other locations

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...

Enrolling

Non-small Cell Lung Cancer

Drug: Nab-paclitaxel

Drug: Pembrolizumab

Phase 3

AstraZeneca

Berlin, Germany and 290 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Lung Cancer in .css-epvm6{white-space:nowrap;}Berlin, BE

Related conditions:

Lung Cancer trials near Berlin, BE, DEU:

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung01)

Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer (IDeate-Lung02)

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer (Krascendo 1)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Find clinical trials for Lung Cancer in Berlin, BE